Korro Bio, Inc. Debt Securities, Available-for-sale, Amortized Cost
Korro Bio, Inc. (KRRO) had Debt Securities, Available-for-sale, Amortized Cost of $113.28 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost $113.28M.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $95.42M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $63.20M.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost $78.18M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost | Debt Securities, Available-for-sale, Amortized Cost as first filed |
|---|---|---|
| 2026-06-30 | $113.28M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $95.42M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $63.20M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $78.18M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $85.91M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $74.67M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $107.23M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $105.29M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $96.60M 10-Q · filed 2024-08-13 | |
| 2023-06-30 | $6.57M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $25.80M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $18.92M 10-K · filed 2024-03-26 | $61.93M 10-K · filed 2023-03-10 |
| 2022-09-30 | $85.78M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $102.83M 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |